STOCK PURCHASE AGREEMENTStock Purchase Agreement • October 7th, 2024 • TNF Pharmaceuticals, Inc. • In vitro & in vivo diagnostic substances
Contract Type FiledOctober 7th, 2024 Company IndustryThis Stock Purchase Agreement (“Agreement”) is made and entered into as of October 1, 2024 (“Effective Date”), between TNF Pharmaceuticals, Inc. (the “Company”) and Prevail Partners, LLC (“Prevail Partners”), Tax ID# 27-0256095. The Company and Prevail Partners are collectively referred to herein as the “Parties.”